Drug Shortage Report for APO-VALPROIC ACID ORAL SOLUTION
| Report ID | 182684 |
| Drug Identification Number | 02238370 |
| Brand name | APO-VALPROIC ACID ORAL SOLUTION |
| Common or Proper name | VALPROIC ACID |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | VALPROIC ACID |
| Strength(s) | 250MG |
| Dosage form(s) | SOLUTION |
| Route of administration | ORAL ORAL |
| Packaging size | 450 mL |
| ATC code | N03AG |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2023-07-30 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-12-06 |
| Company comments | Product to be discontinued |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2023-07-31 | English | Compare |
| v2 | 2023-01-30 | French | Compare |
| v1 | 2023-01-30 | English | Compare |
Showing 1 to 3 of 3